Outcomes of newly diagnosed stage II ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab Meeting Abstract

  

Authors:	Washington, C. R.; Miller, A.; Moore, K. N.; Bell-McGuinn, K. M.; Schilder, R.; Walker, J. L.; Brady, W. E.; O'Cearbhaill, R. E.; Guntupalli, S. R.; Armstrong, D. K.; Hagemann, A. R.; Gray, H. J.; Duska, L. R.; Mathews, C. A.; Chen, A.; O'Malley, D. M.; Gordon, S. W.; Aghajanian, C.
Abstract Title:	Outcomes of newly diagnosed stage II ovarian, primary peritoneal and fallopian tube cancer receiving intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab
Meeting Title:	51st Annual Meeting of the Society of Gynecologic Oncology (SGO)
Journal Title:	Gynecologic Oncology
Volume:	159
Issue:	Suppl. 1
Meeting Dates:	2020 Mar 28-31
Meeting Location:	Toronto, Canada
ISSN:	0090-8258
Publisher:	Elsevier Inc.
Date Published:	2020-10-01
Start Page:	88
Language:	English
ACCESSION:	WOS:000579556200175
DOI:	10.1016/j.ygyno.2020.05.067
PROVIDER:	wos
Notes:	Meeting Abstract: 179 -- This meeting was cancelled due to COVID-19 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/173896